期刊簡介 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Medicina Intensiva LetPub Score 5.0
50 ratings
Rate
Reputation 6.1 Influence 3.7 Speed 7.0 | ||||||||||||||||
期刊簡稱 | MED INTENSIVA | ||||||||||||||||
ISSN | 0210-5691 | ||||||||||||||||
E-ISSN | 1578-6749 | ||||||||||||||||
h-index | 24 | ||||||||||||||||
CiteScore |
| ||||||||||||||||
自引率 (2023-2024) | 22.20%自引率趨勢 | ||||||||||||||||
掲載範囲 |
| ||||||||||||||||
官方網站 | http://www.journals.elsevier.com/medicina-intensiva/ | ||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/MEDINTENSIVA | ||||||||||||||||
開放訪問 | No | ||||||||||||||||
出版商 | Ediciones Doyma, S.L. | ||||||||||||||||
主題領域 | CRITICAL CARE MEDICINE | ||||||||||||||||
出版國/地區 | SPAIN | ||||||||||||||||
發行頻率 | |||||||||||||||||
創刊年 | 197 | ||||||||||||||||
每年文章數 | 52每年文章數趨勢 | ||||||||||||||||
黃金OA百分比 | 5.33% | ||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0210-5691%5BISSN%5D | ||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Slow, 6-12 Week(s) | ||||||||||||||||
競爭力 * | 來自作者的數據: Easy | ||||||||||||||||
參考鏈接 |
| ||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Medicina Intensiva] 的評論 | 撰寫評論 |
作者: 北岳洋泽 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-12 22:02:48 評論於 What does this "Pendiente del Editor" status mean? Does it mean it's going to be rejected?(0) 讚! | 北岳洋泽 |
作者: 万花良工 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-06-14 13:46:56 評論於 I will be at your place in four days(0) 讚! | 万花良工 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 20:00:37 評論於 The corresponding author of a SCI journal article does not necessarily have to be only one person, and there is no fixed standard for how many there can be. This is because different SCI journals have different policies regarding the number of corresponding authors. For SCI journals that only allow one corresponding author, if the article lists multiple corresponding authors, the first corresponding author will be automatically selected. For SCI journals that allow two corresponding authors, two corresponding authors can be listed. The same applies to other requirements. In other words, the number of corresponding authors listed by the authors must comply with the regulations of the target SCI journal. The first author of a SCI paper is the person who has made the greatest contribution to the experiment and writing of the article, and is the person who is listed first in the list of authors. However, in collaborative work, it is common to have cases of co-first authors. There is no clear rule on the number of co-first authors, as it is closely related to the workload, length and publication regulations of the paper, as well as the recognition of the institution. Generally, it is common to have 2-4 first authors for a SCI paper(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 18:10:52 評論於 Yes(0) 讚! | 维尔娜菲茨杰拉德 |
作者: Darlene Pepys 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 22:08:46 評論於 How many corresponding authors/first authors can a journal have?(0) 讚! | Darlene Pepys |
作者: 北国博达 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 16:42:12 評論於 Do all authors receive an email after their article is accepted?(0) 讚! | 北国博达 |
作者: 云韶可爱吗 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-12-17 13:10:47 評論於 Waiting for your good news Wu Puqi 2019-09-11 08:44:00: It seems like not many people have submitted articles. It has been a month since I submitted one, and it is still in the "Pending Editor" status. I don't know if it will be accepted or not. Anyone else who has submitted articles before?(0) 讚! | 云韶可爱吗 |
作者: 水桥玉琅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-09-11 12:35:11 評論於 It seems like not many people submitted their work. It has been a month since I submitted, and it's still in the "Pending Editor" status. I don't know what will happen. Is there anyone else who has submitted their work?(0) 讚! | 水桥玉琅 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us